Compared with those with NFG, patients with IFG and diabetes were more likely to have abnormal levels of laboratory markers, including increased liver enzymes, decreased albumin and estimated glomerular filtration rate (eGFR), elevated cystatin C, creatine kinase, d-dimer and fibrinogen, positive urine protein, higher levels of inflammatory markers (CRP, ESR, procalcitonin, LDH, and neutrophil-to-lymphocyte ratio) and systolic blood pressure (Table 2). The gene discussed is CST3; the disease is diabetes mellitus.